The TRPC6 Gene Focal Segmental Glomerulosclerosis Type 2 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the TRPC6 gene, which are implicated in the development of Focal Segmental Glomerulosclerosis (FSGS) Type 2, a rare and severe form of kidney disease. FSGS Type 2 is characterized by scarring in the kidney's filtering units, leading to significant kidney function decline. The TRPC6 gene plays a crucial role in the regulation of ion channels within the kidney, and mutations in this gene can disrupt kidney function, leading to the disease.
This genetic test is conducted at DNA Labs UAE, a state-of-the-art facility known for its comprehensive genetic testing services. The test involves collecting a DNA sample, typically through a blood draw, and analyzing the genetic material for specific mutations in the TRPC6 gene that are associated with FSGS Type 2. The cost of the test is 4400 AED, and it provides crucial information for the diagnosis and management of this condition. Early detection through genetic testing can help in planning appropriate treatment strategies, potentially slowing the progression of the disease and improving the quality of life for affected individuals.
The CD2AP Gene Focal Segmental Glomerulosclerosis Type 3 Genetic Test is a specialized diagnostic tool designed to identify mutations in the CD2AP gene, which are associated with the development of Focal Segmental Glomerulosclerosis (FSGS) Type 3, a rare and severe form of kidney disease. FSGS Type 3 affects the glomeruli, the filtering units within the kidneys, leading to significant kidney damage and often progressing to kidney failure. Early detection through genetic testing can aid in understanding the disease's progression, potential treatments, and management strategies.
This test is particularly relevant for individuals with a family history of FSGS or unexplained kidney problems, as it can provide crucial insights into their condition. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures accuracy and confidentiality in handling patient samples. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting that accompanies this advanced genetic testing service. By opting for this test, patients and healthcare providers can make informed decisions about treatment options and potential lifestyle adjustments to manage the condition effectively.
The APOL1 Gene Focal Segmental Glomerulosclerosis Type 4 Susceptibility Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to assess an individual's risk of developing Focal Segmental Glomerulosclerosis (FSGS) Type 4. This condition is a severe form of kidney disease that can lead to significant health complications, including kidney failure. The test specifically targets the APOL1 gene, which has been identified as a significant risk factor for FSGS among certain populations. Variations in the APOL1 gene can significantly increase an individual's susceptibility to developing this kidney disease.
The process involves a detailed analysis of the patient's genetic material to identify mutations in the APOL1 gene that are associated with an increased risk of FSGS Type 4. The results of this test can provide valuable information for patients and their healthcare providers, enabling them to understand their risk level and potentially take preventive measures or consider early interventions to manage the condition more effectively.
The cost of the APOL1 Gene Focal Segmental Glomerulosclerosis Type 4 Susceptibility Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated nature of the genetic testing and analysis required to accurately assess the risk associated with the APOL1 gene variations. Patients interested in undergoing this test should contact DNA Labs UAE for more information on the procedure, preparation, and any additional details related to the testing process.
The INF2 Gene Focal Segmental Glomerulosclerosis Type 5 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the INF2 gene, which are known to cause Focal Segmental Glomerulosclerosis Type 5 (FSGS Type 5). FSGS Type 5 is a rare and serious condition that affects the kidney's filtering units, leading to significant kidney damage and, potentially, kidney failure. The test is crucial for individuals with a family history of kidney diseases or those presenting symptoms of FSGS, as it helps in the early detection and management of the condition.
Priced at 4400 AED, the test involves analyzing the patient's DNA to look for specific mutations in the INF2 gene that are associated with the development of FSGS Type 5. By identifying these genetic markers, healthcare providers can make informed decisions about treatment options, potentially tailor therapies to the individual's genetic makeup, and provide genetic counseling for affected families. The test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, accurate results for patients and their families.
The MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the MYO1E gene, which are linked to the development of Focal Segmental Glomerulosclerosis (FSGS) Type 6. FSGS is a disease that affects the kidney's filtering units, leading to serious conditions such as nephrotic syndrome and, ultimately, kidney failure. The identification of a mutation in the MYO1E gene through this test can provide crucial information for the diagnosis, prognosis, and personalized treatment planning for affected individuals. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic anomalies associated with this condition, thereby offering a targeted approach to understanding and managing this specific type of FSGS. By opting for this genetic test at DNA Labs UAE, patients and healthcare providers can gain valuable insights into the genetic underpinnings of FSGS Type 6, facilitating early intervention and tailored therapeutic strategies.
The PAX2 Gene Focal Segmental Glomerulosclerosis Type 7 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the PAX2 gene, which are associated with Focal Segmental Glomerulosclerosis Type 7 (FSGS7). FSGS7 is a rare genetic disorder that affects the kidneys, leading to scarring (glomerulosclerosis) within the organ's filtering units, potentially resulting in significant kidney damage and, ultimately, kidney failure. This test plays a crucial role in the early detection and management of the condition, allowing for personalized treatment plans and genetic counseling for affected individuals and their families. The test is priced at 4400 AED, reflecting the intricate technology and expertise required to accurately analyze and interpret the genetic variations within the PAX2 gene. By opting for this test at DNA Labs UAE, patients gain access to comprehensive genetic insights, facilitating informed healthcare decisions and proactive management of FSGS7.
The "ANLN Gene Focal Segmental Glomerulosclerosis Type 8 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the ANLN gene, which are associated with Focal Segmental Glomerulosclerosis Type 8 (FSGS8). FSGS8 is a rare form of kidney disease that affects the glomeruli, the filtering units of the kidney, leading to proteinuria, nephrotic syndrome, and potentially chronic kidney disease. Early and accurate diagnosis through genetic testing can be crucial in managing and treating the condition effectively.
This test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify the specific genetic mutations of the ANLN gene associated with FSGS8. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of the condition, enabling tailored treatment plans and potentially improving patient outcomes.
The "CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, aimed at detecting mutations in the CRB2 gene, which are linked to Focal Segmental Glomerulosclerosis (FSGS) Type 9. FSGS is a disease that affects the kidney's filtering units, leading to severe renal impairment and, in many cases, chronic kidney disease. The CRB2 gene plays a crucial role in the development and functioning of podocytes, cells essential for the kidney's filtering mechanism. Mutations in this gene can disrupt podocyte function, leading to the characteristic scarring observed in FSGS.
This genetic test is crucial for individuals who have a family history of FSGS or exhibit symptoms related to kidney dysfunction, as early detection can significantly influence the management and prognosis of the condition. By precisely identifying the genetic mutation, healthcare providers can tailor treatment strategies to the patient's specific needs, potentially slowing the progression of the disease and preserving kidney function for as long as possible.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the specialized nature of the assessment and the sophisticated technology employed in the analysis. For patients and families facing the challenges of FSGS, this test represents a critical step in understanding their condition and navigating the path towards optimal care and treatment.
The LAMA5 gene plays a crucial role in the development and maintenance of the kidney's filtering units, known as glomeruli. Mutations in the LAMA5 gene can lead to a condition known as Focal Segmental Glomerulosclerosis (FSGS), a severe disease characterized by scarring (sclerosis) in the glomeruli. This condition can lead to significant kidney damage and, ultimately, kidney failure.
DNA Labs UAE offers a specialized genetic test aimed at detecting mutations in the LAMA5 gene that are associated with FSGS. This test is critical for individuals with a family history of FSGS or those exhibiting symptoms of the disease, as early detection can significantly impact the management and treatment options available.
The cost of the LAMA5-related genetic test at DNA Labs UAE is 4400 AED. This investment can provide invaluable information for affected individuals and their families, guiding treatment decisions and offering insights into the risk of FSGS for future generations.
The INHBA Gene FSH Releasing Protein Deficiency Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect deficiencies in the protein responsible for the release of follicle-stimulating hormone (FSH) due to mutations in the INHBA gene. This gene plays a critical role in reproductive biology, influencing fertility and various hormonal functions. A deficiency can lead to reproductive issues and hormonal imbalances, making this test crucial for individuals experiencing related symptoms or those with a family history of fertility issues. The test, priced at 4400 AED, involves a comprehensive analysis of the INHBA gene to identify any mutations that may be affecting FSH production. Conducted in the state-of-the-art facilities of DNA Labs UAE, it provides valuable insights for personalized treatment plans and informed family planning decisions.
